Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Maxim Integrated Products, Inc.

9.6% sales growth and 39.17% return on equity

Maxim Integrated Products, Inc. designs, develops, manufactures, and markets a range of linear and mixed-signal integrated circuits in the United States, China, rest of Asia, Europe, and internationally.

Maxim Integrated Products, Inc.’s sales growth this year is anticipated to be 13% and 5.2% for next year.

Year-on-year quarterly revenue growth grew by 16.2%, now sitting on 2.28B for the twelve trailing months.

Maxim Integrated Products, Inc.’s sales growth for the next quarter is 9.6%. The company’s growth estimates for the ongoing quarter and the next is 21.4% and 13.1%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 39.17%.

Volatility

Maxim Integrated Products, Inc.’s last day, last week, and last month’s average volatility was 1.29%, 0.65%, and 0.25%, respectively.

Maxim Integrated Products, Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 1.89%, 1.67%, and 1.82%, respectively.

Maxim Integrated Products, Inc.’s Stock Yearly Top and Bottom Value

Maxim Integrated Products, Inc.’s stock is valued at $88.65 at 01:22 EST, under its 52-week high of $88.79 and way higher than its 52-week low of $41.93.

Maxim Integrated Products, Inc.’s Moving Average

Maxim Integrated Products, Inc.’s value is above its 50-day moving average of $84.36 and way higher than its 200-day moving average of $72.25.

2. Newmont Mining Corporation

47.8% sales growth and 10.48% return on equity

Newmont Corporation engages in the production and exploration of gold, copper, silver, zinc, and lead.

Newmont Mining Corporation’s sales growth this year is expected to be 18.2% and 22.7% for next year.

Year-on-year quarterly revenue growth grew by 16.8%, now sitting on 11.08B for the twelve trailing months.

Newmont Mining Corporation’s sales growth for the next quarter is 47.8%. The company’s growth estimates for the ongoing quarter and the next is 82% and 177.5%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.48%.

Volatility

Newmont Mining Corporation’s last day, last week, and last month’s average volatility was a negative 0.15%, a negative 0.33%, and a positive 0.10%, respectively.

Newmont Mining Corporation’s last day, last week, and last month’s high and low average amplitude percentage was 1.63%, 2.19%, and 2.34%, respectively.

Newmont Mining Corporation’s Stock Yearly Top and Bottom Value

Newmont Mining Corporation’s stock is valued at $60.39 at 01:22 EST, way below its 52-week high of $72.22 and way above its 52-week low of $33.00.

Newmont Mining Corporation’s Moving Average

Newmont Mining Corporation’s worth is under its 50-day moving average of $60.76 and below its 200-day moving average of $62.98.

3. AbbVie

50.4% sales growth and 209.12% return on equity

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the United States, Japan, Germany, Canada, France, Spain, Italy, the Netherlands, the United Kingdom, Brazil, and internationally.

AbbVie’s sales growth this year is anticipated to be 37.2% and 17.9% for next year.

Year-on-year quarterly revenue growth grew by 52.2%, now sitting on 40.65B for the twelve trailing months.

AbbVie’s sales growth for the next quarter is 50.4%. The company’s growth estimates for the current quarter and the next is 29.4% and 18.2%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 209.12%.

Volatility

AbbVie’s last day, last week, and last month’s average volatility was a negative 1.65%, a positive 0.41%, and a positive 0.02%, respectively.

AbbVie’s last day, last week, and last month’s high and low average amplitude percentage was 3.36%, 1.85%, and 2.00%, respectively.

AbbVie’s Stock Yearly Top and Bottom Value

AbbVie’s stock is valued at $106.50 at 01:22 EST, below its 52-week high of $109.15 and way higher than its 52-week low of $62.55.

AbbVie’s Moving Average

AbbVie’s value is above its 50-day moving average of $104.05 and way above its 200-day moving average of $95.29.

4. Advanced Semiconductor Engineering, Inc.

19.9% sales growth and 11.61% return on equity

ASE Technology Holding Co., Ltd.

Advanced Semiconductor Engineering, Inc.’s sales growth this year is anticipated to be 20.5% and 8.5% for next year.

Year-on-year quarterly revenue growth grew by 4.8%, now sitting on N/A for the twelve trailing months.

Advanced Semiconductor Engineering, Inc.’s sales growth for the next quarter is 19.9%. The company’s growth estimates for the present quarter and the next is a negative 0% and negative -20%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.61%.

Volatility

Advanced Semiconductor Engineering, Inc.’s last day, last week, and last month’s average volatility was 2.96%, 0.89%, and 0.68%, respectively.

Advanced Semiconductor Engineering, Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 1.89%, 1.67%, and 1.80%, respectively.

Advanced Semiconductor Engineering, Inc.’s Stock Yearly Top and Bottom Value

Advanced Semiconductor Engineering, Inc.’s stock is valued at $5.91 at 01:22 EST, under its 52-week high of $5.93 and way higher than its 52-week low of $3.17.

Advanced Semiconductor Engineering, Inc.’s Moving Average

Advanced Semiconductor Engineering, Inc.’s worth is above its 50-day moving average of $5.39 and way higher than its 200-day moving average of $4.67.

5. T

71% sales growth and 5.95% return on equity

T-Mobile US, Inc., through its subsidiaries, provides wireless services for branded postpaid and prepaid, and wholesale customers in the United States, Puerto Rico, and the United States Virgin Islands.

T’s sales growth this year is expected to be 50.3% and 15.4% for next year.

Year-on-year quarterly revenue growth grew by 74.2%, now sitting on 59.93B for the twelve trailing months.

News about T today

IPO lockup expiration alert: poseida therapeutics (pstx). According to today’s article on Business Insider, "Last October, Poseida signed a collaboration agreement with TScan Therapeutics to explore developing allogeneic T cell receptor therapies for the treatment of COVID-19."

T’s sales growth for the next quarter is 71%. The company’s growth estimates for the ongoing quarter and the next is a negative 43.7% and negative -42.7%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.95%.

Volatility

T’s last day, last week, and last month’s average volatility was 0.11%, 0.16%, and 0.01%, respectively.

T’s last day, last week, and last month’s high and low average amplitude percentage was 1.00%, 1.55%, and 1.59%, respectively.

T’s Stock Yearly Top and Bottom Value

T’s stock is valued at $133.49 at 01:22 EST, below its 52-week high of $134.76 and way higher than its 52-week low of $63.50.

T’s Moving Average

T’s worth is higher than its 50-day moving average of $130.62 and way higher than its 200-day moving average of $116.09.

Previous days news about T

Y-biologics signed license agreement with 3d medicines for T cell bispecific engager in greater China territory. According to Business Insider on Tuesday, 5 January, "This clustering formation can generate strong T cell activation signaling and induce cancer cell killing potency.", "Through ALiCE technology, we will strengthen our novel therapeutic portfolio by presenting a variety of competitive novel I/O therapeutic candidates in the CD3-based T cell bispecific engager market, which is a key trend in the field of bispecific antibody. "

6. South Plains Financial, Inc.

20.2% sales growth and 12.14% return on equity

South Plains Financial, Inc. operates as a bank holding company for City Bank that provides commercial and consumer financial services to small and medium-sized businesses and individuals.

South Plains Financial, Inc.’s sales growth this year is expected to be 37.7% and a negative 9.3% for next year.

Year-on-year quarterly revenue growth grew by 41.2%, now sitting on 186.39M for the twelve trailing months.

South Plains Financial, Inc.’s sales growth for the next quarter is 20.2%. The company’s growth estimates for the ongoing quarter and the next is 34.5% and 78.9%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.14%.

Volatility

South Plains Financial, Inc.’s last day, last week, and last month’s average volatility was a negative 1.01%, a positive 0.10%, and a negative 0.00%, respectively.

South Plains Financial, Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 2.03%, 2.14%, and 2.85%, respectively.

South Plains Financial, Inc.’s Stock Yearly Top and Bottom Value

South Plains Financial, Inc.’s stock is valued at $18.90 at 01:32 EST, way below its 52-week high of $22.00 and way higher than its 52-week low of $11.30.

South Plains Financial, Inc.’s Moving Average

South Plains Financial, Inc.’s value is higher than its 50-day moving average of $18.24 and way higher than its 200-day moving average of $14.94.

7. Terreno Realty Corporation

7.3% sales growth and 5.25% return on equity

Terreno Realty Corporation and together with its subsidiaries, the “Company”) acquires, owns and operates industrial real estate in six major coastal U.S. markets: Los Angeles, Northern New Jersey/New York City, San Francisco Bay Area, Seattle, Miami, and Washington, D.C. All square feet, acres, occupancy and number of properties disclosed in these condensed notes to the consolidated financial statements are unaudited.

Terreno Realty Corporation’s sales growth this year is anticipated to be 8.5% and 8.5% for next year.

Year-on-year quarterly revenue growth grew by 8.6%, now sitting on 183.02M for the twelve trailing months.

Terreno Realty Corporation’s sales growth for the next quarter is 7.3%. The company’s growth estimates for the ongoing quarter and the next is a negative 13.6% and negative -5.3%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.25%.

Volatility

Terreno Realty Corporation’s last day, last week, and last month’s average volatility was a positive 0.49%, a negative 0.00%, and a negative 0.02%, respectively.

Terreno Realty Corporation’s last day, last week, and last month’s high and low average amplitude percentage was 2.23%, 2.30%, and 2.07%, respectively.

Terreno Realty Corporation’s Stock Yearly Top and Bottom Value

Terreno Realty Corporation’s stock is valued at $58.01 at 01:32 EST, under its 52-week high of $64.24 and way above its 52-week low of $42.12.

Terreno Realty Corporation’s Moving Average

Terreno Realty Corporation’s value is under its 50-day moving average of $58.06 and above its 200-day moving average of $57.32.

8. BanColombia S.A.

50.8% sales growth and 3.58% return on equity

Bancolombia S. A. provides various banking products and services to individual and corporate customers in Colombia, Panama, Puerto Rico, El Salvador, Costa Rica, and Guatemala.

BanColombia S.A.’s sales growth this year is anticipated to be 16.1% and 4.9% for next year.

Year-on-year quarterly revenue growth declined by 30.4%, now sitting on N/A for the twelve trailing months.

BanColombia S.A.’s sales growth for the next quarter is 50.8%. The company’s growth estimates for the current quarter and the next is a negative 68.4% and 2.9%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.58%.

Volatility

BanColombia S.A.’s last day, last week, and last month’s average volatility was a positive 0.79%, a negative 0.70%, and a positive 1.33%, respectively.

BanColombia S.A.’s last day, last week, and last month’s high and low average amplitude percentage was 1.39%, 2.65%, and 3.34%, respectively.

BanColombia S.A.’s Stock Yearly Top and Bottom Value

BanColombia S.A.’s stock is valued at $40.60 at 01:32 EST, way below its 52-week high of $56.10 and way higher than its 52-week low of $16.27.

BanColombia S.A.’s Moving Average

BanColombia S.A.’s value is way above its 50-day moving average of $34.51 and way higher than its 200-day moving average of $28.83.

LEAVE A REPLY

Please enter your comment!
Please enter your name here